http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10030233-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b15e3f34ffe5010cbac30d6bb9031350 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-04 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y106-02004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0042 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 |
filingDate | 2016-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f15b9ccea7bdb4516382a8d67cba991d |
publicationDate | 2018-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-10030233-B2 |
titleOfInvention | Modified P450 reductase with N-terminal deletions and endoplasmic reticulum retention tag |
abstract | The present invention provides an isolated or recombinant polypeptide comprising or consisting of a modified P450 reductase which lacks N-terminal amino acids relative to the corresponding wild type P450 reductase and comprises an epitope tag comprising the sequence HDEL or KDEL. The modified P450 reductase, when co-expressed with a cytochrome P450, increases the activity and/or expression of the cytochrome P450 compared to the activity and/or expression of the cytochrome P450 when co-expressed with the wild type P450 reductase. |
priorityDate | 2013-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 394.